These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
206 related items for PubMed ID: 25656957
1. A preliminary analysis of microRNA as potential clinical biomarker for schizophrenia. Sun XY, Zhang J, Niu W, Guo W, Song HT, Li HY, Fan HM, Zhao L, Zhong AF, Dai YH, Guo ZM, Zhang LY, Lu J, Zhang QL. Am J Med Genet B Neuropsychiatr Genet; 2015 Apr; 168B(3):170-8. PubMed ID: 25656957 [Abstract] [Full Text] [Related]
3. Aberrant microRNA expression in peripheral plasma and mononuclear cells as specific blood-based biomarkers in schizophrenia patients. Sun XY, Lu J, Zhang L, Song HT, Zhao L, Fan HM, Zhong AF, Niu W, Guo ZM, Dai YH, Chen C, Ding YF, Zhang LY. J Clin Neurosci; 2015 Mar; 22(3):570-4. PubMed ID: 25487174 [Abstract] [Full Text] [Related]
4. Alterations of miR-132 are novel diagnostic biomarkers in peripheral blood of schizophrenia patients. Yu HC, Wu J, Zhang HX, Zhang GL, Sui J, Tong WW, Zhang XY, Nie LL, Duan JH, Zhang LR, Lv LX. Prog Neuropsychopharmacol Biol Psychiatry; 2015 Dec 03; 63():23-9. PubMed ID: 25985888 [Abstract] [Full Text] [Related]
5. Clinical evaluation of microRNA expression profiling in non small cell lung cancer. Markou A, Sourvinou I, Vorkas PA, Yousef GM, Lianidou E. Lung Cancer; 2013 Sep 03; 81(3):388-396. PubMed ID: 23756108 [Abstract] [Full Text] [Related]
6. miR-181b-5p, miR-195-5p and miR-301a-3p are related with treatment resistance in schizophrenia. Alacam H, Akgun S, Akca H, Ozturk O, Kabukcu BB, Herken H. Psychiatry Res; 2016 Nov 30; 245():200-206. PubMed ID: 27552670 [Abstract] [Full Text] [Related]
7. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer. Zhu XL, Ren LF, Wang HP, Bai ZT, Zhang L, Meng WB, Zhu KX, Ding FH, Miao L, Yan J, Wang YP, Liu YQ, Zhou WC, Li X. World J Gastroenterol; 2019 Apr 07; 25(13):1580-1591. PubMed ID: 30983818 [Abstract] [Full Text] [Related]
9. Serum hsa-miR-30e As a Potential Biomarker to Predict the Effect of Neoadjuvant Chemoradiation Therapy in Locally Advanced Rectal Cancer. Chen W, Wang W. Genet Test Mol Biomarkers; 2021 Nov 07; 25(11):696-706. PubMed ID: 34788143 [Abstract] [Full Text] [Related]
12. Abnormal miRNA-30e Expression is Associated with Breast Cancer Progression. Lin Z, Li JW, Wang Y, Chen T, Ren N, Yang L, Xu W, He H, Jiang Y, Chen X, Liu T, Liu G. Clin Lab; 2016 Nov 07; 62(1-2):121-8. PubMed ID: 27012041 [Abstract] [Full Text] [Related]
13. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection. Zekri AN, Youssef AS, El-Desouky ED, Ahmed OS, Lotfy MM, Nassar AA, Bahnassey AA. Tumour Biol; 2016 Sep 07; 37(9):12273-12286. PubMed ID: 27271989 [Abstract] [Full Text] [Related]
17. MicroRNA signature constituted of miR-30d, miR-93, and miR-181b is a promising prognostic marker in primary central nervous system lymphoma. Takashima Y, Kawaguchi A, Iwadate Y, Hondoh H, Fukai J, Kajiwara K, Hayano A, Yamanaka R. PLoS One; 2019 Sep 07; 14(1):e0210400. PubMed ID: 30615673 [Abstract] [Full Text] [Related]
18. Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas. Yang C, Wang C, Chen X, Chen S, Zhang Y, Zhi F, Wang J, Li L, Zhou X, Li N, Pan H, Zhang J, Zen K, Zhang CY, Zhang C. Int J Cancer; 2013 Jan 01; 132(1):116-27. PubMed ID: 22674182 [Abstract] [Full Text] [Related]
19. Plasma MicroRNA-34a as a Potential Biomarker for Early Diagnosis of Esophageal Cancer. Lin Y, Lin Z, Fang Z, Li H, Zhi X, Zhang Z. Clin Lab; 2019 Nov 01; 65(11):. PubMed ID: 31710448 [Abstract] [Full Text] [Related]
20. Evaluation of miRNA-9 and miRNA-34a as potential biomarkers for diagnosis of breast cancer in Iranian women. Orangi E, Motovali-Bashi M. Gene; 2019 Mar 01; 687():272-279. PubMed ID: 30468908 [Abstract] [Full Text] [Related] Page: [Next] [New Search]